The oncology sector – like most of the healthcare sector – has been struggling post-COVID boom, faltering in the face of a tight financial market reluctant.
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) will present two of its abstracts at an annual conference of the International Society of Cell & Gene Therapy (ISCT) in France later this month.
Washington, DC (PRWEB) September 13, 2022 NDA Partners’ General Manager, Eric Fish, announced today that Michael Mendicino, PhD, a highly regarded subject